SYRE · IV Rank History

Spyre Therapeutics, Inc. Common Stock

IV rank shows where SYRE's implied volatility sits within its own recent range: 0 is the lowest reading in the window, 100 the highest. This page gives the 52-week version, the 90-session version our screeners use, the IV percentile, and the daily history.

SYRE's 30-day at-the-money implied volatility was 73.8% as of Oct 26, 2026. Its 52-week IV rank is 18 and its IV percentile is 23%: IV was lower on 23% of the past year's sessions. Over those 52 weeks it ranged from 57.9% (Sep 16, 2026) to 144.3% (Mar 23, 2026). On the 90-session window our screeners use, the IV rank is 34.

SYRE IV rank history

504 sessions

Filled line: 90-session IV rank (0–100, left axis). Dashed line: 30-day at-the-money implied volatility (right axis).

SYRE IV rank and implied volatility as of 2026-10-26

52-Week IV Rank
18
0 = year low, 100 = year high
IV Percentile
23%
of past-year sessions had lower IV
90-Session IV Rank
34
used by our screeners
30-Day ATM IV
73.8%
1-year average 85.4%
52-Week IV High
144.3%
2026-03-23
52-Week IV Low
57.9%
2026-09-16
History Since
2024-04-09
617 sessions

How these are measured. Implied volatility here is SYRE's 30-day at-the-money IV: the implied volatility of the calls and puts struck nearest the share price, blended between the expirations on either side of 30 days so every reading covers the same horizon. It's the IV level options traders usually quote, and it doesn't jump when the nearest expiration rolls from a weekly to a monthly. The 7-day figure is the same measure a week out, so it reacts first to near-term events such as earnings.

52-week IV rank = (today's IV − 52-week low) ÷ (52-week high − 52-week low) × 100. IV percentile is the share of the past year's sessions that closed with lower IV than today. The 90-session IV rank applies the same rank formula to the last 90 sessions, so it reacts faster.

A high reading means SYRE options are expensive relative to their own recent history, which is common ahead of earnings or after a sharp move. It says nothing about which way the stock will go. The Vol Arb Screener ranks every tracked symbol by these measures.

SYRE implied volatility by month

MonthAvg ATM IVHighLowAvg IV Rank (90-session)
Oct 2026 (to date) 72.0% 78.4% 64.5% 30
Sep 2026 65.6% 77.8% 57.9% 10
Aug 2026 86.8% 104.7% 70.6% 36
Jul 2026 77.7% 83.3% 72.0% 12
Jun 2026 78.2% 81.8% 73.7% 12
May 2026 73.5% 78.4% 68.9% 8
Apr 2026 95.5% 137.1% 71.1% 37
Mar 2026 129.1% 144.3% 104.6% 96
Feb 2026 86.9% 104.5% 75.4% 40
Jan 2026 77.8% 86.5% 66.4% 16
Dec 2025 79.0% 96.6% 69.9% 25
Nov 2025 94.3% 103.7% 73.3% 44
Oct 2025 100.3% 127.9% 68.7% 48
Sep 2025 99.8% 138.8% 68.5% 39
Aug 2025 93.9% 136.3% 59.1% 27
Jul 2025 103.4% 133.9% 63.1% 33
Jun 2025 97.1% 146.1% 65.3% 27
May 2025 109.6% 183.9% 64.5% 39
Apr 2025 113.9% 159.8% 84.2% 55
Mar 2025 109.5% 129.1% 90.3% 52
Feb 2025 91.3% 118.8% 69.7% 27
Jan 2025 91.8% 110.5% 75.0% 28
Dec 2024 89.3% 98.0% 74.1% 24
Nov 2024 106.9% 147.1% 70.7% 48
Oct 2024 124.0% 137.4% 105.2% 90
Sep 2024 104.3% 119.5% 91.9% 89
Aug 2024 87.7% 104.1% 70.8% 34
Jul 2024 85.3% 93.3% 78.7% 31
Jun 2024 82.5% 102.5% 60.4% 23
May 2024 81.9% 98.8% 68.8% 6
Apr 2024 96.1% 139.9% 84.4% —

SYRE IV rank: last 30 sessions

DateIV Rank (90-session)30-Day ATM IV7-Day ATM IV
2026-10-26 34 73.8% —
2026-10-23 38 75.9% —
2026-10-22 34 73.7% —
2026-10-21 36 74.6% —
2026-10-20 33 73.1% —
2026-10-19 36 75.0% —
2026-10-16 44 78.4% —
2026-10-15 32 73.0% —
2026-10-14 29 71.6% 79.4%
2026-10-13 35 74.1% 60.6%
2026-10-12 35 74.1% 82.9%
2026-10-09 24 69.3% 70.8%
2026-10-08 27 70.4% 68.5%
2026-10-07 30 71.8% 73.4%
2026-10-06 25 69.5% 65.4%
2026-10-05 18 66.5% 65.8%
2026-10-02 14 64.5% 60.1%
2026-10-01 18 66.1% 57.9%
2026-09-30 16 65.2% 63.4%
2026-09-29 17 65.6% 63.7%
2026-09-28 14 64.4% 64.2%
2026-09-25 16 65.2% 63.5%
2026-09-24 9 61.9% —
2026-09-23 7 61.3% —
2026-09-22 13 64.2% —
2026-09-21 7 61.0% —
2026-09-18 11 62.9% —
2026-09-17 8 61.8% —
2026-09-16 0 57.9% 95.0%
2026-09-15 5 62.6% 82.7%

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.